Understanding cancer biology through protein analysis
CPTAC BIOSPECIMEN COLLECTION
['FUNDING_OTHER'] · LEIDOS BIOMEDICAL RESEARCH, INC. · NIH-10668926
This study is looking at how proteins in different types of cancer work and change, so we can learn more about cancer and find better treatments that are tailored just for you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LEIDOS BIOMEDICAL RESEARCH, INC. (nih funded) |
| Locations | 1 site (FREDERICK, UNITED STATES) |
| Trial ID | NIH-10668926 on ClinicalTrials.gov |
What this research studies
This research focuses on improving our understanding of cancer by analyzing proteins and their modifications in various cancer types. By conducting detailed proteogenomic analyses, the project aims to identify key driver genes and understand how cancer develops at a molecular level. Patients may benefit from insights gained about their specific cancer types, which could lead to more targeted and effective treatments. The research involves collecting and analyzing biospecimens from patients with specific cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with specific types of malignant neoplasms or cancers who are willing to provide biospecimens for analysis.
Not a fit: Patients with non-malignant conditions or those not diagnosed with cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments based on a deeper understanding of cancer biology.
How similar studies have performed: Other research in proteogenomics has shown promise in enhancing our understanding of cancer biology and improving treatment strategies, indicating that this approach is both relevant and potentially impactful.
Where this research is happening
FREDERICK, UNITED STATES
- LEIDOS BIOMEDICAL RESEARCH, INC. — FREDERICK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: THIAGARAJAN, MATHANGI — LEIDOS BIOMEDICAL RESEARCH, INC.
- Study coordinator: THIAGARAJAN, MATHANGI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer, Disease, Disorder